Literature DB >> 25591725

Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion.

Feyzullah Besli1, Cengiz Basar, Mesut Kecebas, Yasin Turker.   

Abstract

PURPOSE: This study evaluated the response to electrical cardioversion (EC) and the effect on the myocardial performance index (MPI) in patients with persistent and long-standing persistent atrial fibrillation (AF).
METHODS: We enrolled 103 patients (mean age 69.6 ± 8.9 years, 40.7% males) with a diagnosis of persistent and long-standing persistent AF. EC was applied to all patients after one g of amiodarone administration. Echocardiographic findings before EC were compared in patients with successful versus unsuccessful cardioversions and in patients with maintained sinus rhythm (SR) versus those with AF recurrence at the end of the first month. We also compared echocardiographic data before EC versus at the end of the first month in the same patients with maintained SR.
RESULTS: SR was achieved in 72.8% of patients and was continued at the end of the first month in 69.3% of the patients. The MPI value of all patients was found to be 0.73 ± 0.21. The size of the left atrium was determined to be an independent predictor of the maintenance of SR at 1 month. In subgroup analyses, when we compared echocardiographic findings before EC and at the end of the first month in patients with maintained SR, the MPI (0.66 ± 0.14 vs 0.56 ± 0.09, p < 0.001) values were significantly decreased.
CONCLUSIONS: Our study is the first to show impairment of the MPI, which is an indicator of systolic and diastolic function, in patients with persistent and long-standing persistent AF and improvement of the MPI after successful EC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25591725     DOI: 10.1007/s10840-014-9965-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  40 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection.

Authors:  Krishnamoorthy Vivekananthan; Thomachan Kalapura; Mandeep Mehra; Carl Lavie; Richard Milani; Robert Scott; Myung Park
Journal:  Am J Cardiol       Date:  2002-09-01       Impact factor: 2.778

3.  Myocardial performance index derived from pre-ejection period as a novel and useful predictor of cardiovascular events in atrial fibrillation.

Authors:  Chun-Yuan Chu; Wen-Hsien Lee; Po-Chao Hsu; Hung-Hao Lee; Cheng-An Chiu; Ho-Ming Su; Tsung-Hsien Lin; Chee-Siong Lee; Hsueh-Wei Yen; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  J Cardiol       Date:  2014-08-22       Impact factor: 3.159

4.  Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

Authors:  C Tei; R A Nishimura; J B Seward; A J Tajik
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

5.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

6.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.

Authors:  C Tei; K S Dujardin; D O Hodge; R A Kyle; A J Tajik; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

7.  Appraisal of electroconversion in treatment of cardiac dysrhythmias.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1968-11

8.  Effects of valve dysfunction on Doppler Tei index.

Authors:  Amdadul Haque; Yutaka Otsuji; Shiro Yoshifuku; Toshiro Kumanohoso; Hui Zhang; Akira Kisanuki; Shinichi Minagoe; Ryuzo Sakata; Chuwa Tei
Journal:  J Am Soc Echocardiogr       Date:  2002-09       Impact factor: 5.251

9.  Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.

Authors:  Jacob E Møller; Ulf Dahlström; Ole Gøtzsche; Avijit Lahiri; Knud Skagen; Gert Steen Andersen; Kenneth Egstrup
Journal:  Am Heart J       Date:  2004-03       Impact factor: 4.749

10.  Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study.

Authors:  Anne Bernard-Brunet; Christophe Saint Etienne; Eric Piver; Noura Zannad; Jean-Christophe Pagés; Laurent Fauchier; Dominique Babuty
Journal:  J Transl Med       Date:  2014-02-22       Impact factor: 5.531

View more
  1 in total

1.  Relationship Between Tei Index and PEP-Derived Myocardial Performance Index in Sinus Rhythm.

Authors:  Feyzullah Besli; Cengiz Basar; Ismail Ekinozu; Yasin Turker
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.